The Award Ceiling for Year 1 is 0 (none).
CDC anticipates an Approximate Total Fiscal Year Funding amount of $7,000,000 for Year 1, subject to the availability of funds.High-quality laboratory systems and services are essential for accurate diagnosis, treatment, and management of HIV and opportunistic
infections (OI) amongst people living with HIV (PLHIV).
Mozambique has made tremendous progress toward building technical capacity and optimizing the laboratory network to provide timely access to early infant diagnosis (EID) and viral load (VL) testing services for all eligible clients.
VL coverage has rapidly increased from 67% in 2018, to 83% in 2022, contributing to improved patient monitoring and outcomes for PLHIV.
This NOFO plans to build upon current accomplishments and support government institutions in Mozambique to strengthen and sustain laboratory systems and services towards achieving the UNAIDS 95-95-95 goals.The NOFO aims to attain comprehensive coverage for both VL and EID testing, facilitate the expansion of HIV testing for enhanced case detection, strengthen the diagnosis of TB and other OI, enhance the governance of laboratory systems, build technical, scientific, and managerial capabilities, and implement robust laboratory data and quality management systems (QMS).
This approach encompasses comprehensive quality assurance (QA) and continuous quality improvement (QI) programs essential for HIV rapid test site certification and laboratory accreditation.
This NOFO seeks to strengthen integration of laboratory systems and services to support multi-disease testing and improve responsiveness to emerging public health threats.
Related ProgramsGlobal AIDS
Department of Health and Human Services